Home » Pharma News (page 10)

Pharma News

Nerve Block Technique Might Help Ease Chronic Back Pain

Nerve Block Technique Might Help Ease Chronic Back Pain A procedure that uses radio waves to treat chronic low back pain provided long-lasting relief to a small group of patients, researchers report. Called intradiscal biacuplasty (IDB), the procedure uses two water-cooled needles to blast radiofrequency energy at the nerve fibers within and around a spinal disc that’s begun to degenerate ... Read More »

Views on 100% FDI in Medical devices by Dr. GSK Velu, Trivitron

Views on 100% FDI in Medical devices by Dr. GSK Velu, Trivitron BY DR. GSK VELU, FOUNDER AND MANAGING DIRECTOR, TRIVITRON GROUP OF COMPANIES: New Delhi, Jan 03, 2015: “While 100‎% FDI in Medical Devices sector is a welcome in our opinion this was already in existence and many MNCs have 100% subsidiaries in India though predominantly with trading and distribution ... Read More »

Diabetes drug may prevent recurring strokes

Diabetes drug may prevent recurring strokes Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance but without diabetes. The results of the Insulin Resistance Intervention after Stroke (IRIS) trial, presented at the International Stroke Conference 2016 in Los Angeles and published in the New England Journal of Medicine, suggest ... Read More »

Natco Pharma Bags Award For Invention

Natco Pharma Bags Award For Invention Natco Pharma Limited has been awarded the first prize for the best invention category by the Exhibition Society of Andhra Pradesh. The governor, S S Barnala, gave away the prize carrying a certificate and a cash prize of Rs 30,000 to A K S Bhujanga Rao, the vice-president (R&D) of Natco Pharma, at a ... Read More »

Sun Pharma Q3 beats estimates, profit jumps 28%; revenue up 3.6%

 Sun Pharma Q3 beats estimates, profit jumps 28%; revenue up 3.6% Drug major Sun Pharmaceutical Industries   ‘ third quarter earnings surpassed analysts’ expectations on Friday with profit rising 28 percent sequentially (up 258.3 percent year-on-year) to Rs 1,416.6 crore. Bottomline on sequential basis was boosted by other income, lower tax cost and good operational performance while lower tax expenses ... Read More »

USFDA issues warning letter to Ipca Labs for 3 plants

USFDA issues warning letter to Ipca Labs for 3 plants Drug firm Ipca Laboratories said it has received a warning letter from the health regulator USFDA for three of its facilities. The US regulator had earlier imposed an import ban for not adhering to the good manufacturing norms. “USFDA carried out inspections at Ipca’s laboratories our manufacturing units situated at ... Read More »

Glenmark starts studies on new drug aimed at cancer treatment

Glenmark starts studies on new drug aimed at cancer treatment Glenmark Pharmaceuticals on Friday announced discovery and initiation of enabling studies of an investigational new drug (IND) molecule targeted at cancer treatment. The novel clinical development candidate, GBR1342 is an antibody based on the company’s proprietary BEAT platform, Glenmark Pharmaceuticals said in a regulatory filing. BEAT is Glenmark’s technology for ... Read More »

Lincoln Pharma tanks 20% after product ban in Tanzania

Lincoln Pharma tanks 20% after product ban in Tanzania Lincoln Pharmaceuticals was locked in lower circuit of 20% at Rs 179 on the BSE after the company said thatTanzania drug authority (TFDA) has announced to stop and banned importing of Chloramphenicol Sodium Succinate Injection and also cancelled the company’s registration. “In this circumstance a huge quantity dispatched by the company ... Read More »

UniQure’s gene therapy increases clotting in some hemophilia B patients

UniQure’s gene therapy increases clotting in some hemophilia B patients UniQure said preliminary results from the low-dose cohort in a phase I/II clinical trial assessing its AAV5/FIX gene therapy, AMT-060, in patients with moderately severe to severe hemophilia B demonstrated a significant clinical benefit in two participants. The company said all five patients in the low-dose cohort had Factor IX ... Read More »

Glenmark receives tentative US FDA approval for generic Multaq tablets

Glenmark receives tentative US FDA approval for generic Multaq tablets Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (US FDA) for its dronedarone tablets, 400 mg, the generic version of Multaq tablets, 400 mg of Sanofi-Aventis US, LLC. ‘Tentative approval’ means that FDA has concluded that a drug product has ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes